Trends and challenges in a VUCA world

Utkarsh Palnitkar, Partner, National Head – Infrastructure, Government & Healthcare National Head – Life Sciences practice, KPMG India informs that the VUCA world has thrown up a new set of exigencies and pharma leaders need to possess adaptive skills to overcome them.

Volatility, Uncertainty,Complexity and Ambi-guity (VUCA) characterise any business environment today. Moreover, VUCA has led to an increased recognition that new and unprecedented risks are emerging all the time. The pharma industry is also operating in this environment, and is increasingly facing challenges in its day-today operations. Industrial complexities are being accentuated by changing demographics, technology and innovations, globalisation, products and services variations, etc. These complexities are posing a new set of exigencies, which require pharma leaders to possess adaptive skills. It has, therefore, become highly important for leaders to foresee upcoming trends and plan ahead of the competition to succeed. The following VUCA trends and challenges are impacting the pharma industry, and leaders must prepare themselves in advance to overcome these

Empowered patients moving towards convenience

Technology Enabled Care (TEC) for improving quality, enhancing patient experience and reducing cost

TEC involves the convergence of technology, digital and mobile telecommunications. It can help to effectively integrate care by empowering patients to self-manage their health. Cumulative data collated through multiple initiatives of telemedicine, telehealth, telecare, digital-health devices, mHealth, eHealth and remote monitoring solutions provides access to the verifiable, real-time patient-generated data. This data enables physicians to plan progressive care and avoid adverse health events, keeping patients healthy even out of clinical facilities.

Home-based care for convenience and flexibility